Karen Kelly

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Ebaa Al-Obeidi, Karen Kelly, David R Gandara, Jonathan W Riess
CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report. JCO precision oncology 8 (2024)
Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics analysis reveals immune features associated with immunotherapy benefit in squamous cell lung cancer patients from Phase III Lung-MAP S1400I trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kelly
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N Waqar, Martin J Edelman, Ellen V Sigal, Stacey J Adam, Shakun Malik, Charles D Blanke, Michael L LeBlanc, Karen Kelly, Jhanelle E Gray, Mary W Redman
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP). JCO precision oncology 7 (2023)
Philip C Mack, Jieling Miao, Mary W Redman, James Moon, Sarah B Goldberg, Roy S Herbst, Mary Ann Melnick, Zenta Walther, Fred R Hirsch, Katerina Politi, Karen Kelly, David R Gandara
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Jason John Luke, Fabrice Barlesi, Ki Chung, Anthony W Tolcher, Karen Kelly, Antoine Hollebecque, Christophe Le Tourneau, Vivek Subbiah, Frank Tsai, Steven Kao, Philippe A Cassier, Mustafa Khasraw, Hedy L Kindler, Hua Fang, Frances Fan, Kathryn Allaire, Maulik Patel, Shiming Ye, Debra T Chao, William R Henner, Joel S Hayflick, Michael A McDevitt, Lawrence Fong
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors. Journal for immunotherapy of cancer 9 (2) (2022)
Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highleyman, Vassiliki Papadimitrakopoulou, Joel W Neal, Saiama N Waqar, Jyoti D Patel, Jhanelle E Gray, David R Gandara, Karen Kelly, Roy S Herbst
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, Roy S Herbst, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760). Journal for immunotherapy of cancer 9 (8) (2022)
D Ross Camidge, Fabrice Barlesi, Jonathan Wade Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E Vokes, Alexander I Spira, Eric Angevin, Wu-Chou Su, David S Hong, John H Strickler, Monica Motwani, Martin Dunbar, Apurvasena Parikh, Elysa Noon, Vincent Blot, Jun Wu, Karen Kelly
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jacob M Sands, Sumithra J Mandrekar, David E Kozono, Geoffrey R Oxnard, Shauna L Hillman, Dennis A Wigle, Ramaswamy Govindan, Jennifer Wilkinson Carlisle, Jhanelle E Gray, Joseph K Salama, Luis E Raez, Apar Ganti, Nathan Foster, Shakun Malik, Jeffrey Bradley, Karen Kelly, Suresh R Ramalingam, Thomas E Stinchcombe
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO). Immunotherapy 13 (9) (2021)
Karen Kelly, Juliane Manitz, Manish R Patel, Sandra P D' Angelo, Andrea B Apolo, Arun Rajan, Vijay Kasturi, Isabell Speit, Marcis Bajars, John Warth, James L Gulley
Efficacy and immune-related adverse event associations in avelumab-treated patients. Journal for immunotherapy of cancer 8 (2) (2021)
Joshua A Roth, Meghna S Trivedi, Stacy W Gray, Donald L Patrick, Debbie M Delaney, Kate Watabayashi, Paul Litwin, Parth Shah, Katherine D Crew, Monica Yee, Mary W Redman, Joseph M Unger, Vassiliki Papadimitrakopoulou, Judy Johnson, Karen Kelly, David R Gandara, Roy S Herbst, Dawn L Hershman, Scott D Ramsey
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). JCO oncology practice 17 (11) (2021)
D Ross Camidge, Daniel Morgensztern, Rebecca S Heist, Minal Barve, Everett E Vokes, Jonathan Wade Goldman, David S Hong, Todd M Bauer, John H Strickler, Eric Angevin, Monica Motwani, Apurvasena Parikh, Zhaowen Sun, Bruce Allen Bach, Jun Wu, Philip B Komarnitsky, Karen Kelly
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)